188 unchanged sentences
5 to the Company's Registration Statement on Form 10 filed on November 16, 2012).**
−Removed: *AbbVie 2013 Incentive Stock Program (incorporated by reference to Exhibit A to the AbbVie Inc.
+Added: *AbbVie 2013 Amended and Restated Incentive Stock Program (incorporated by reference to Appendix C to the AbbVie Inc.
Definitive Proxy Statement on Schedule 14A dated March 22, 2021).
−Removed: 2013 Incentive Stock Program Second Amendment (incorporated by reference to Exhibit 10.5 of the company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2019).**
−Removed: *AbbVie Performance Incentive Plan, as amended and restated (incorporated by reference to Exhibit 10.4 of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015).**
+Added: AbbVie Performance Incentive Plan, as amended and restated .**
*AbbVie Deferred Compensation Plan, as amended and restated (incorporated by reference to Exhibit 10.5 of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2016).**
−Removed: Supplemental Pension Plan, as amended and restated (incorporated by reference to Exhibit 10.2 of the company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2019).**
−Removed: Supplemental Savings Plan, as amended and restated (incorporated by reference to Exhibit 10.8 of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015).
+Added: AbbVie Supplemental Pension Plan, as amended and restated .**
+Added: AbbVie Supplemental Savings Plan, as amended and restated .
*Form of AbbVie Inc.
4 unchanged sentences
Non-Qualified Stock Option Agreement (incorporated by reference to Exhibit 10.2 of the company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2016).**
−Removed: 2020 Form 10-K |
−Removed: Exhibit Description
*Form of AbbVie Inc.
2 unchanged sentences
Non-Qualified Stock Option Agreement (incorporated by reference to Exhibit 10.2 of the company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2017).**
−Removed: *Form of AbbVie Inc.
−Removed: Performance Share Award Agreement (incorporated by reference to Exhibit 10.2 of the company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2018).**
−Removed: *Form of AbbVie Inc.
−Removed: Performance-Vested Restricted Stock Unit Agreement (incorporated by reference to Exhibit 10.1 of the company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2018).**
+Added: | 2021 Form 10-K
+Added: Exhibit Description
*Form of AbbVie Inc.
24 unchanged sentences
and the lenders party thereto (incorporated by reference to Exhibit 10.1 of the company’s Current Report on Form 8-K filed on June 25, 2019).
−Removed: *Term Loan Credit Agreement, dated as of July 12, 2019, among AbbVie Inc., certain lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (incorporated by reference to Exhibit 10.1 of the company’s Current Report on Form 8-K filed on July 16, 2019).
*Underwriting Agreement, dated September 17, 2019, among AbbVie Inc.
6 unchanged sentences
(acting for themselves and as representatives of the several initial purchasers named therein) (incorporated by reference to Exhibit 1.1 of the company’s Current Report on Form 8-K filed on November 13, 2019).
+Added: *Form of AbbVie Inc.
+Added: Performance-Vested Restricted Stock Unit Agreement (incorporated by reference to Exhibit 10.
+Added: 1 of the company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 202 1 ).
+Added: *Form of AbbVie Inc.
+Added: Performance Share Award Agreement (incorporated by reference to Exhibit 10.2 of the company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021).**
+Added: * Form of AbbVie Inc.
+Added: Non-Employee Director RSU Agreement (US) (incorporated by reference to Exhibit 10.
+Added: 3 of the company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021) .**
+Added: * Form of AbbVie Inc.
+Added: Non-Qualified Stock Option Agreement (incorporated by reference to Exhibit 10.
+Added: 4 of the company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021) .**
+Added: *Form of AbbVie Inc.
+Added: Retention RSU Agreement - Ratable Vesting (incorporated by reference to Exhibit 10.5 of the company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021).**
Subsidiaries of AbbVie Inc.
42 unchanged sentences
(Principal Executive Officer) Robert A.
−Removed: Executive Vice President,
+Added: Vice Chairman, Finance and Commercial Operations and
Chief Financial Officer
25 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.